Rumored Buzz on pharma blogs
January 21, 2025 In 21 CFR 211.94 it can be mentioned that “Drug item containers and closures shall not be reactive, additive, or absorptive to change the security, id, power, high-quality or purity of your drug beyond the official or recognized demands.” Even though the code will make this statement, and if expanded on while in the similar FDA